Back
Manhattan Associates Vs. Mirum Pharmaceuticals Industry Stock Comparison
Buy
73
MANH
Manhattan Associates
Last Price:
280.46
Seasonality Move:
12.15%
Sell
45
MIRM
Mirum Pharmaceuticals
Last Price:
38.87
Seasonality Move:
5.99%
Buy
73
Manhattan Associates (MANH)
is a Buy
Is Manhattan Associates a Buy, Sell or Hold?
- The current Manhattan Associates [MANH] share price is $283.80. The Score for MANH is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- MANH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Mirum Pharmaceuticals (MIRM)
is a Sell
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $38.72. The Score for MIRM is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- MIRM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MANH Stock Price Chart
What is Manhattan Associates's stock price today?
-
The Manhattan Associates share price today is $283.80
The current trend is moderately bullish and MANH is experiencing slight selling pressure.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $38.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIRM is experiencing slight selling pressure.
MANH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 7.79 | Buy |
Relative Strength Index (14 RSI): | 68.9 | Buy |
Chaikin Money Flow: | -62582 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (256.45 - 276.19) | Buy |
Bollinger Bands (100): | (224.52 - 261.8) | Buy |
MIRM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.56 | Sell |
Relative Strength Index (14 RSI): | 41.61 | Sell |
Chaikin Money Flow: | -57139 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.33 - 42.57) | Sell |
Bollinger Bands (100): | (28.23 - 41.85) | Buy |
MANH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 278.49 | Buy |
20-day SMA: | 267.67 | Buy |
50-day SMA: | 256.31 | Buy |
200-day SMA: | 237.99 | Buy |
8-day EMA: | 278.78 | Buy |
20-day EMA: | 270.54 | Buy |
50-day EMA: | 259.35 | Buy |
200-day EMA: | 236.55 | Buy |
MIRM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.01 | Sell |
20-day SMA: | 40.52 | Sell |
50-day SMA: | 40.71 | Sell |
200-day SMA: | 31.23 | Buy |
8-day EMA: | 39.24 | Sell |
20-day EMA: | 40.05 | Sell |
50-day EMA: | 39.32 | Sell |
200-day EMA: | 33.16 | Buy |
Manhattan Associates Earnings Growth & MANH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $0.13 per share, an increase this year of $0.77 per share, and an increase next year of $0.46 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.30 per share, an increase this year of $1.79 per share, and an increase next year of $0.88 per share.
Manhattan Associates Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Mirum Pharmaceuticals Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |